2024 HCPCS Code J7627
Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
TAGS: inhalation administered through compounded
Short Description | Budesonide comp unit |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2007 |
HCPCS Code Added Date | January 01, 2006 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9217 - Leuprolide acetate suspnsion
- J9218 - Leuprolide acetate injeciton
- J9219 - Leuprolide acetate implant
- J9223 - Inj. lurbinectedin, 0.1 mg
- J9225 - Vantas implant
- J9226 - Supprelin la implant
- J9227 - Inj. isatuximab-irfc 10 mg
- J9228 - Ipilimumab injection
- J9229 - Inj inotuzumab ozogam 0.1 mg
- J9230 - Mechlorethamine hcl inj
- J9245 - Inj melpha hydroch nos 50 mg
- J9246 - Inj., evomela, 1 mg
- J9247 - Inj, melphalan flufenami 1mg
- J9248 - Inj melphalan (hepzato) 1 mg
- J9249 - Inj, melphalan (apotex) 1 mg
- J9250 - Methotrexate sodium inj
- J9255 - Inj, methotrexate (accord)
- J9258 - Paclitaxel (teva)
- J9259 - Paclitaxel (american regent)
- J9260 - Inj methotrexate sodium 50mg